Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy

Pediatric Blood and Cancer

Volumn 50, Issue 5, 2008, Pages 1060-1062

  Kanwar, Vikramjit S ^a   Heath, Jessica ^a   Krasner, Carolyn N ^b   Pearce, Jennifer M ^a  

^a ALBANY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemotherapy; Ovarian cancer; Pediatric oncology; Rare tumors

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CELECOXIB; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IMATINIB; THALIDOMIDE; VINBLASTINE;

ABDOMINAL MASS; ADOLESCENT; ADVANCED CANCER; ARTICLE; BONE MARROW SUPPRESSION; CANCER REGRESSION; CANCER STAGING; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; LETHALITY; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUROTOXICITY; OVARY CARCINOMA; PRIORITY JOURNAL; RARE DISEASE; SMALL CELL CARCINOMA; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; OVARIAN NEOPLASMS; PIPERAZINES; PYRAZOLES; PYRIMIDINES; SULFONAMIDES; THALIDOMIDE; VINBLASTINE;

EID: 41849090827     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21333     Document Type: Article

References (14)

1. Young RH, Olia E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type: A clinicopathological analysis of 150 cases. Am J Surg Pathol 1994;18:1102-1116.
2. Harrison ML, Hoskins P, du Bois A, et al. Small cell carcinoma of the ovary, hypercalcemic type - analysis of combined experience and recommendation for management. A GCIG study. Gynecol Oncol 2006;100:233-238.
3. Gadducci A, Cosuio S, Zola P, et al. Surveillance procedures for patients treated for epithelial ovarian cancer: A review of the literature. Int J Gynecol Cancer 2007;17:21-31.
4. Senekjian ES, Weiser PA, Talerman A, et al. Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin and etoposide in the treatment of small cell carcinoma of the ovary. Cancer 1989;64: 1183-1188.
5. Tewari K, Brewer C, Cappuccini F, et al. Advanced-stage small cell carcinoma of the ovary in pregnancy: Long-term survival after surgical debulking and multiagent chemotherapy. Gynecol Oncol 1997;66:531-534.
6. Dickersin GR, Kline IW, Scully RE. Small cell carcinoma of the ovary with hypercalcemia: A report of 11 cases. Cancer 1982; 49:188-197.
7. Benrubi GI, Pitel P, Lammert N. Small cell carcinoma of the ovar with hypercalcemia responsive to sequencing chemotherapy. South Med J 1993;86:247-248.
8. Powell JL, McAfee RD, McCoy RC, et al. Uterine and ovarian conservation in advanced small cell carcinoma of the ovary. Obstet Gynecol 1998;91:846-848.
9. Rana S, Warren BK, Yamada SD. Stage IIIC small cell carcinoma of the ovary: Survival with conservative surgery and chemotherapy. Obstet Gynecol 2004;103:1120-1123.
10. Saulnier Sholler GL, Luks F, Mangray S, et al. Advanced small cell carcinoma of the ovary in a pediatric patient with long term survival and review of the literature. J Pediatr Hematol Oncol 2005;27:168-172.
11. Hamilton S, Beattie GJ, Williams ARW. Small cell carcinoma of the ovary: A report of three cases and review of the literature. J Obstet Gynecol 2004;24:169-172.
12. Schmandt RE, Broaddus R, Lu KH, et al. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-β in ovarian serous carcinoma and normal ovarian surface epithelium. Cancer 2003;98:758-764.
13. Shaw TJ, Vanderheyden B. AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate. Gynecol Oncol 2007;105:122-131.
14. Kieran MW, Turner C, Rubin JB, et al. A Feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer. J Pediatr Hematol Oncol 2005;27:573-581.